If a triple combination treatment is used for long-term benefits in persons with cystic fibrosis (CF), researchers discovered that airway mucus is less sticky and lung inflammation is significantly reduced. According to their studies, this kind of drug helps a lot of people with CF symptoms.
Researchers found that airway mucus is less sticky and lung inflammation is greatly reduced if triple combination treatment is used for long-term benefits in people with cystic fibrosis (CF). According to their research, this type of drug relieves the symptoms of CF in many people.
Mucus in the airways is less sticky, and lung inflammation is greatly reduced: In individuals with cystic fibrosis (CF), triple combination treatment can produce these long-term benefits.